Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms
J6 · Effective Apr 1, 2019
75 active Medicare policies list C69.20, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Apr 1, 2019
JK · Effective Apr 1, 2019
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
9 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of C69.20 |
|---|---|---|
| Anecortave Acetate (Retaane) | Sep 20, 2023 | Covered |
| Brachytherapy | Jun 6, 2023 | Covered |
| Fibroid Treatment | Feb 15, 2024 | Covered |
| Fluocinolone Acetonide Intra-vitreal Implant (Retisert, Yutiq and Iluvien) | Jan 5, 2024 | Covered |
| Optic Nerve and Retinal Imaging Methods | May 17, 2023 | Covered |
| Transpupillary Thermal Therapy | Jul 14, 2023 | Covered |
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J15 · Effective Dec 26, 2021
JE · Effective Jan 2, 2022
JF · Effective Jan 2, 2022
JJ · Effective Dec 26, 2021
JM · Effective Dec 26, 2021
J5 · Effective Dec 26, 2021
J8 · Effective Dec 26, 2021
J15 · Effective Feb 10, 2020
JE · Effective May 17, 2020
JF · Effective May 17, 2020
JJ · Effective Feb 10, 2020
JM · Effective Feb 10, 2020
J5 · Effective Feb 9, 2020
J8 · Effective Feb 9, 2020
J15 · Effective Jul 27, 2020
JE · Effective Dec 26, 2022
JF · Effective Dec 26, 2022
JJ · Effective Feb 3, 2020
JM · Effective Feb 3, 2020
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Nov 12, 2023
JM · Effective Nov 12, 2023
J9 · Effective Oct 1, 2015
JJ · Effective Jun 12, 2017
JM · Effective Jun 12, 2017
J6 · Effective Apr 1, 2026
J6 · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Aug 6, 2026
National · Effective Aug 13, 2026
J5 · Effective Aug 6, 2026
National · Effective Aug 6, 2026
National · Effective Mar 12, 2026
National · Effective Aug 6, 2026
J5 · Effective Aug 6, 2026
National · Effective Sep 24, 2026
J5 · Effective Sep 24, 2026
National · Effective Sep 24, 2026
National · Effective Sep 24, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Jul 1, 2025
National · Effective Jul 1, 2025
National · Effective Feb 5, 2026
National · Effective Jun 4, 2026
National · Effective Oct 30, 2025
National · Effective Jan 1, 2026
J9 · Effective Oct 1, 2025
National · Effective Jul 1, 2026
National · Effective Oct 1, 2026
| Verteporfin (Visudyne) Photodynamic Therapy | Jun 29, 2023 | Covered |
|---|
| Vitrectomy | Jun 22, 2023 | Covered |
|---|
| Policy | Effective | Status of C69.20 |
|---|---|---|
| Hematopoietic Stem Cell Transplantation for Pediatric Solid Tumors | Jan 6, 2026 | Covered |